Canadian-Listed Biotech & Life Sciences ETFs
Funds that hold companies developing new drugs, genomics and medical research.
About this category
Compare Canadian-listed ETFs in the Biotech & Life Sciences category. Biotech and life sciences ETFs hold companies involved in drug development, genomics and medical research. Portfolios can be concentrated, and company values can change sharply after clinical or regulatory news.
Plain funds2
Plain fund assetsCA$30M
Largest companies, share of the money
- Moderna9.2%
- Genmab A/S5.6%
- Twist Bioscience4.9%
- Regeneron Pharmaceuticals3.5%
- Exelixis3.5%
- Together26.8%
Weighted by fund assets. Holdings data covers all 2 funds.
The funds
| Returns | ||||||||
|---|---|---|---|---|---|---|---|---|
| Select | Watchlist | Fund | ||||||
| XDNA.TOiShares Genomics Immunology and Healthcare Index ETF | CA$22M | 0.44% | +63.1% | +66.4% | +32.4% | 0.2% | ||
| FBT.TOFirst Trust NYSE Arca Biotechnology ETF | CA$8M | 0.71% | +32.9% | +45.2% | +27.1% | 0.0% | ||
- XDNA.TO1 yr+66.4%iShares Genomics Immunology and Healthcare Index ETFAssets CA$22MMER 0.44%
- FBT.TO1 yr+45.2%First Trust NYSE Arca Biotechnology ETFAssets CA$8MMER 0.71%
Prices and AUM are shown in Canadian dollars. Return percentages are calculated from the CAD-listed class. Listing currency does not by itself describe the currency exposure of the fund's holdings. CAD hedging is shown separately.
More in Sectors
Healthcare9Global Financial Sector21Real Estate & REIT17Global Infrastructure19Utilities5Industrials3Consumer7Telecom3Canadian Financial Sector13
All equity themes
Regions
Technology
Sectors
Styles
Measure biotechnology exposure within your healthcare holdings
Explore →